COMMUNIQUÉS West-GlobeNewswire

Press Release: Beyfortus public health advantage bolstered by first real-world comparison of infant vs maternal RSV immunization programs
29/05/2025
Beyfortus public health advantage bolstered by first real-world comparison of infant vs maternal RSV immunization programs Late-breaking data show infant respiratory syncytial virus (RSV) hospitalizations reduced by 69 [...]
Jay Glazer and Wife Rosie Glazer Offer Candid Look at ADHD and Relationships in New Qelbree® Content Series with Supernus Pharmaceuticals
29/05/2025
New video series explores the impact of ADHD on relationships and the role of Qelbree in helping Jay’s ADHD symptom management ROCKVILLE, Md., May 29, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals is expanding its [...]
Organic Living Soil LLC Joins Easy Environmental Solutions as Exclusive Dealer in Louisiana and Mississippi Following Initial Shipment
29/05/2025
WELCOME, Minn., May 29, 2025 (GLOBE NEWSWIRE) -- Digital Utilities Ventures, Inc. (OTC: DUTV), now doing business as Easy Environmental Solutions Inc., is proud to announce that Organic Living Soil, LLC has agreed to be [...]
Gain Therapeutics Announces Oral Presentation at 2nd GBA1 Meeting
29/05/2025
BETHESDA, Md., May 29, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of [...]
Cannabix Technologies Enters Contract Manufacturing Agreement with Price Industries for BreathLogix Devices
29/05/2025
Cannabix has developed an autonomous alcohol breathalyzer screening device for employers and a range of industries and safety settings VANCOUVER, British Columbia, May 29, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies [...]
BioAge Labs completes IND-enabling studies for BGE-102, a potent, orally available, brain-penetrant NLRP3 inhibitor, and advances candidate toward the clinic
29/05/2025
IND submission planned for mid-2025 with Phase 1 SAD data anticipated by year end BGE-102 induced weight loss in preclinical obesity models, both as monotherapy and in combination with GLP-1 receptor agonists Internally [...]
Lantern’s Cancer Program Reaches 1 Million Member Milestone
29/05/2025
Lantern also announces clinical team and partner expansion to deliver accelerated treatment DALLAS, May 29, 2025 (GLOBE NEWSWIRE) -- Lantern , the leading Specialty Care Platform connecting approximately 6 million [...]
Parexel Showcases Oncology Expertise at ASCO 2025; Company Selected to Present Five Posters at World’s Largest Oncology Event
29/05/2025
Parexel also launching a comprehensive Radiopharmaceuticals report at the meeting Onsite Parexel experts include recently appointed Chief Medical Officer and veteran oncologist Dr. Charlotte Moser, licensed medical [...]
HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone
29/05/2025
Southlake, TX, May 29, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (“AI”)-powered medical technology company focused on transforming [...]
Progyny Adds Distinguished Healthcare Executive Elizabeth Bierbower to Board of Directors
29/05/2025
NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced the addition of healthcare veteran Elizabeth Bierbower to its [...]
Silexion Therapeutics Announces Groundbreaking Preclinical Results: SIL204 Shows Strong Efficacy in Pancreatic, Colorectal, and Lung Cancers
29/05/2025
Silexion’s Revolutionary RNAi approach demonstrates powerful anti-tumor activity across three major KRAS-driven cancer types; Inhibition rate of ~90% observed in GP2D human colorectal cancer cells; Company to conduct [...]
Positron Corporation Expands Market Presence with Sale of NeuSight PET-CT Scanner
29/05/2025
Niagara Falls, NY, May 29, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leader in molecular imaging systems and services, is pleased to announce the sale of its NeuSight PET [...]
Akari Therapeutics Releases “Meet the Team” Video Featuring Recently Appointed Mark F. Kubik, Head of Business Development – Oncology
29/05/2025
Well-established industry leader whose oncology expertise and transactions record has led to multiple approved therapeutic products and advanced clinical product candidates Access the video here BOSTON and LONDON, May [...]
HealthEquity Community Foundation Awards $35,000 in New Grants
29/05/2025
From food banks to crisis shelters, 14 nonprofits recognized for tackling urgent community needs DRAPER, Utah, May 29, 2025 (GLOBE NEWSWIRE) -- The HealthEquity Community Foundation™ today announced the recipients of [...]
Sienna Senior Living Inc. Announces Results From Annual and Special Meeting
29/05/2025
MARKHAM, Ontario, May 29, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) is pleased to announce that it has received shareholder approval in respect of all resolutions to [...]
Ensemble, On Marche à la Marche Percée DT1
29/05/2025
Tout au long du mois de juin, près de 50 communautés se réuniront dans tout le Canada pour amasser des fonds en faveur de la recherche sur le diabète de type 1 TORONTO, 29 mai 2025 (GLOBE NEWSWIRE) -- La Marche Percée [...]
Together we Walk at Breakthrough T1D Walk
29/05/2025
Throughout June close to 50 communities will be gathering across Canada to raise funds for type 1 diabetes research TORONTO, May 29, 2025 (GLOBE NEWSWIRE) -- Breakthrough T1D™ Walk (formerly JDRF Walk to Cure Diabetes) [...]
A Destructive Form of Cell Death Might Be The Key To Slowing The Human Aging Process
29/05/2025
Experts across scientific and clinical fields, writing in Nature Oncogene, explore the emerging role of necrosis in aging—pointing to its potential to reshape how we understand and treat age-related conditions CAMBRIDGE [...]
Keros Therapeutics Announces TROPOS Topline Data and Corporate Restructuring
29/05/2025
Discontinues Development of Cibotercept in PAH Announces Corporate Restructuring to Align Operations with Ongoing Strategic Priorities LEXINGTON, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros [...]

Pages